Top Markets
Coin of the day
Biostax Corp. Biostax Corp.

Biostax Corp.

BTAX
Ранг среди акций #41904
Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition,... Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition, advancement, and commercialization of various pharmaceutical and biotechnology solutions. A pivotal focus lies on Lodonal, their lead investigational drug candidate, designed as a once-daily immune system modulator aimed at managing both human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). Beyond this primary drug, their portfolio encompasses several innovative programs. These include a Global Telehealth platform and an early-stage Medtech initiative leveraging blockchain and smart contract technologies to enhance the security and management of prescriptions and electronic health records. Furthermore, Biostax is developing JKB-122, an experimental small molecule that acts as a long-duration toll-like receptor 4 (TLR4) antagonist, intended for the treatment of autoimmune hepatitis, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH). Another compound they address is Low Dose Naltrexone, a formula believed to offer immune-modulating advantages pertinent to conditions such as cancer, chronic pain, autoimmune disorders, and anti-aging efforts. The company also pursues development efforts for addressing hyperphosphatemia. Biostax maintains a licensing agreement with Cytocom Inc. and underwent a corporate name change from Immune Therapeutics, Inc. to its current designation in October 2023. The company's operational base is located in Winter Park, Florida.
Цена акции
$0.0001
Последняя синхронизация: 2026-08-11
Рыночная капитализация
$7.87K
Изменение (1 день)
0.00%
Изменение (1 год)
-50.00%
Страна
US
Торговля Biostax Corp. (BTAX)

Категория

Коэффициент P/S для Biostax Corp. (BTAX)
Коэффициент P/S на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Biostax Corp., текущий коэффициент P/S (TTM) составляет 0. В конце 2026 он составлял 0.
История P/S для Biostax Corp. с 2026 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
Недостаточно данных для указанных дат.
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
9.88 -
US
10.30 -
NL
- -
CH
4.98 -
BE
- -
KR